Madrid Auditorium (Hall 2) Educational session

Optimal adjuvant and neo-adjuvant therapy in HER-2+ patients (ID 46)

Date
30.09.2019
Time
16:30 - 18:00
Location
Madrid Auditorium (Hall 2)
Chairs
  • Aleix Prat (Barcelona, Spain)
  • Giampaolo Bianchini (Milano, Italy)
Optimal adjuvant and neo-adjuvant therapy in HER-2+ patients Educational session

Dissecting the heterogeneity of HER2+ breast cancer (ID 150)

Lecture Time
16:30 - 16:55
Speakers
  • Aleix Prat (Barcelona, Spain)
Session Name
Optimal adjuvant and neo-adjuvant therapy in HER-2+ patients
Location
Madrid Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
16:30 - 18:00
Optimal adjuvant and neo-adjuvant therapy in HER-2+ patients Educational session

Lessons learned and opportunities from the neo-adjuvant setting (ID 148)

Lecture Time
16:55 - 17:20
Speakers
  • Lisa Carey (Chapel Hill, NC, United States of America)
Session Name
Optimal adjuvant and neo-adjuvant therapy in HER-2+ patients
Location
Madrid Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
16:30 - 18:00
Optimal adjuvant and neo-adjuvant therapy in HER-2+ patients Educational session

Optimal current regimens in the adjuvant setting (ID 149)

Lecture Time
17:20 - 17:45
Speakers
  • Nadia Harbeck (Munich, Germany)
Session Name
Optimal adjuvant and neo-adjuvant therapy in HER-2+ patients
Location
Madrid Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
16:30 - 18:00
Optimal adjuvant and neo-adjuvant therapy in HER-2+ patients Educational session

Discussion (ID 355)

Lecture Time
17:45 - 18:00
Session Name
Optimal adjuvant and neo-adjuvant therapy in HER-2+ patients
Location
Madrid Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
16:30 - 18:00